Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

The possibility is examined that immunomodulatory pharmacotherapy may be clinically useful in managing the pandemic coronavirus disease 2019 (COVID-19), known to result from infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a positive-sense single-stranded RNA virus. The...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Life Sci
Egile Nagusiak: Morris, Gerwyn, Athan, Eugene, Walder, Ken, Bortolasci, Chiara C., O'Neil, Adrienne, Marx, Wolf, Berk, Michael, Carvalho, André F., Maes, Michael, Puri, Basant K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Inc. 2020
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537668/
https://ncbi.nlm.nih.gov/pubmed/33035581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2020.118541
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak